Invention Grant
US09346878B2 Methods of treating glomerulonephritis associated with IGA nephropathy for TACI-immunoglobulin fusion proteins
有权
治疗IGA肾病与TACI-免疫球蛋白融合蛋白相关的肾小球肾炎的方法
- Patent Title: Methods of treating glomerulonephritis associated with IGA nephropathy for TACI-immunoglobulin fusion proteins
- Patent Title (中): 治疗IGA肾病与TACI-免疫球蛋白融合蛋白相关的肾小球肾炎的方法
-
Application No.: US14331567Application Date: 2014-07-15
-
Publication No.: US09346878B2Publication Date: 2016-05-24
- Inventor: Mark W. Rixon , Jane A. Gross
- Applicant: Zymogenetics, Inc.
- Applicant Address: US WA Seattle
- Assignee: ZYMOGENETICS, INC.
- Current Assignee: ZYMOGENETICS, INC.
- Current Assignee Address: US WA Seattle
- Agency: Womble Carlyle Sandridge & Rice LLP
- Main IPC: A61K39/00
- IPC: A61K39/00 ; A61K45/00 ; C12P21/08 ; C07K16/24 ; C07K14/705 ; A61K39/395 ; A61K45/06 ; A61K38/00
Abstract:
Molecules that interfere with the binding of a tumor necrosis factor receptor with its ligand, such as a soluble receptor, have proven usefulness in both basic research and as therapeutics. The present invention provides improved soluble transmembrane activator and calcium modulator and cyclophilin ligand-interactor (TACI) receptors.
Public/Granted literature
- US20140328844A1 METHODS OF USE FOR TACI-IMMUNOGLOBULIN FUSION PROTEINS Public/Granted day:2014-11-06
Information query
